Will earnings report, end it’s winning streak? NRx Pharmaceuticals (NASDAQ:NRXP)

Earnings results for NRx Pharmaceuticals (NASDAQ:NRXP)

NRX Pharmaceuticals, Inc. is expected* to report earnings on 08/16/2021 after market close. The report will be for the fiscal Quarter ending Jun 2021.

Analyst Opinion on NRx Pharmaceuticals (NASDAQ:NRXP)

Dividend Strength: NRx Pharmaceuticals (NASDAQ:NRXP)

NRx Pharmaceuticals does not currently pay a dividend. NRx Pharmaceuticals does not have a long track record of dividend growth.

Insiders buying/selling: NRx Pharmaceuticals (NASDAQ:NRXP)

In the past three months, NRx Pharmaceuticals insiders have not sold or bought any company stock. 18.51% of the stock of NRx Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 0.12% of the stock of NRx Pharmaceuticals is held by institutions.

Earnings and Valuation of NRx Pharmaceuticals (NASDAQ:NRXP

NRx Pharmaceuticals has a P/B Ratio of 19.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here